ELTP

Elite Pharmaceuticals, Inc.

ELTP·28659T200·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic

ELTP (Elite Pharmaceuticals, Inc.) is held by 0 institutional investors as of Q1 2024.

0
Holders
Avg rating(1 Elite)
$0
Total Value
0% (1)
Fund Consensus
ELTPSmart Money Verdict
View all
Held by 0 funds
1 elite
Who's Trading
InsiderPDPlassche DouglasSell $499KOct 2, 2025
InsiderE/ELITE PHARMACEUTICALS INC /NV/Sell $262KAug 22, 2025
InsiderKKKirkov KirkoBuy $10KJul 10, 2025
InsiderPDPlassche DouglasSell $116KJul 8, 2025
Sign up free to see all 4
View all insider trades
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Fisher Asset Management, LLCFisher Asset Management, LLC
Exited
0(-100.0%)$11,4800.0%+66.67%
0

Continue exploring

Smart money flow
Track where institutional capital is flowing
Discover new institutional entries
Fresh positions initiated this quarter
Check sector trends
Capital flows across GICS sectors

Other Healthcare stocks held by institutions

LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC
413 holders · $186.3B
JNJJOHNSON & JOHNSON
394 holders · $391.3B
DHRDANAHER CORP DEL
392 holders · $97B
ISRGINTUITIVE SURGICAL INC
391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC
391 holders · $147B
BSXBOSTON SCIENTIFIC CORP
389 holders · $76.8B
MRKMERCK & CO INC
385 holders · $208.9B
ABBVABBVIE INC
381 holders · $254.9B
ABTABBOTT LABORATORIES
380 holders · $129.1B
High Conviction Moves-Smart Money Convergence-Fund Consensus-Double-Down Detection

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used